| Views | |
|---|---|
| GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma | 186 |
| January 2025 | February 2025 | March 2025 | April 2025 | May 2025 | June 2025 | July 2025 | |
|---|---|---|---|---|---|---|---|
| GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma | 1 | 14 | 6 | 18 | 10 | 4 | 1 |
| Views | |
|---|---|
| 2021_Zirngibl_etal.pdf | 220 |
